Dietrich John Pauls - 23 Jun 2023 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
President and CEO, Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Issuer symbol
DMAC
Transactions as of
23 Jun 2023
Net transactions value
+$49,997
Form type
4
Filing time
26 Jun 2023, 16:34:35 UTC
Previous filing
02 Jun 2023
Next filing
03 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMAC Voting Common Shares, no par value per share Purchase $49,997 +12,787 +23% $3.91 68,591 23 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.